close
Add to watchlist
Boston Scientific Corp (BSX) Healthcare, Medical Equipment & Supplies
Boston Scientific Corporation operates as a developer, manufacturer, and marketer of medical devices used in various interventional medical specialties worldwide. Its products help physicians and other medical professionals improve the patientsÂ’ quality of life by providing alternatives to surgery. The company's cardiovascular group consists of drug-eluting and bare-metal stents, coronary revascularization products, Intraluminal ultrasound imaging catheters and systems, Embolic protection system, peripheral and neurovascular interventions, electrophysiology devices, and cardiac rhythm management devices. This group's products are used to treat cardiovascular, peripheral vascular and neurovascular diseases, cardiac arrhythmias, and neuro and aortic aneurysms. Its endosurgery group includes esophageal, gastric, and duodenal intervention products; colorectal, pancreatico-biliary, and pulmonary intervention devices; and products for urinary tract intervention and bladder disease, prostate intervention, pelvic floor reconstruction and urinary incontinence, and gynecology. This group's products are used for the treatment of gastrointestinal diseases, esophagitis, portal hypertension, peptic ulcers, esophageal cancer, polyps, inflammatory bowel disease, diverticulitis, colon cancer, and benign prostatic hyperplasia. The company's neuromodulation group comprises Precision Spinal Cord Stimulation system for the treatment of chronic pain of the lower back and legs. Its cardiac rhythm management group offers implantable devices used to treat cardiac arrhythmias and heart failure. Boston Scientific Corporation markets its products through direct sales force, and a network of distributors and dealers. The company was founded in 1979 and is headquartered in Natick, Massachusetts with additional offices in Tokyo, Japan and Paris, France.
(login to add this stock to your watchlist or favorites)
Key Statistics
| Closing Price | 5.88 |
| Volume | (mio) 10.68 |
| Volume Avg | (mio) 14.99 |
| 52 Week High | 7.91 |
| 52 Week Low | 5.01 |
| PE | 20.55 |
| PE (group average) | 39 |
| EPS Year | 0.29 |
| EPS change Q/Q | -81.25% |
| EPS change Q/Q Yr ago | -1000% |
| EPS change Q/Q next Q est | -70% |
| EPS change Y/Y | 1000% |
| REV change Q/Q | -50% |
| REV change Q/Q Yr ago | 0% |
| EPS next Q est | 0.10 |
| EPS next Y est | 0.48 |
| Divident Annual | 0.00 |
| Dividend Yield | 0% |